Sumanta Kumar Pal, MD
Sumanta (Monty) Kumar Pal, MD, FASCO, is an internationally recognized leader in the area of genitourinary cancers, including kidney, bladder, and prostate cancer. He is co-director of City of Hope's Kidney Cancer Program and is the head of the kidney and bladder cancer disease team at the institution.
Articles
Treatment Considerations for Patients With Metastatic Urothelial Carcinoma
May 22nd 2018Sumanta K. Pal, MD, associate professor of the Department of Medical Oncology and Experimental Therapeutics at City of Hope, discusses the data he considers when treating patients with metastatic urothelial carcinoma.
Choosing Second-Line Therapy for Patients With Urothelial Carcinoma
October 10th 2017Sumanta K. Pal, MD, medical oncologist, assistant clinical professor, Department of Medical Oncology and Therapeutics Research, City of Hope, discusses choosing second-line therapy for patients with urothelial carcinoma.
